Cresco Labs Cash Flow from Operating Activities 2020-2025 | CRLBF

Cresco Labs cash flow from operating activities from 2020 to 2025. Cash flow from operating activities can be defined as a company's cash flows from operations.

Cresco Labs Cash Flow from Operating Activities 2020-2025 | CRLBF

Cresco Labs cash flow from operating activities from 2020 to 2025. Cash flow from operating activities can be defined as a company's cash flows from operations.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$228.4B
Boston Scientific (BSX)$153.7B
Stryker (SYK)$149.1B
EssilorLuxottica (ESLOY)$146B
Medtronic (MDT)$115.2B
Lonza Group Ag (LZAGY)$48.5B
Haleon (HLN)$43.7B
ResMed (RMD)$41.9B
Agilent Technologies (A)$34.1B
GE HealthCare Technologies (GEHC)$33.8B
Terumo (TRUMY)$27.8B
Koninklijke Philips (PHG)$26.5B
Insulet (PODD)$23.1B
Zimmer Biomet Holdings (ZBH)$20.7B
Smith & Nephew SNATS (SNN)$16.2B
Baxter (BAX)$12.5B
Sunny Optical Technology (SNPTF)$10.8B
Demant (WILYY)$8.1B
Bio-Rad Laboratories (BIO)$7.8B
Lantheus Holdings (LNTH)$3.7B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.4B
Perrigo (PRGO)$3.2B
Prestige Consumer Healthcare (PBH)$3.2B
ICU Medical (ICUI)$3.1B
Haemonetics (HAE)$2.6B
LeMaitre Vascular (LMAT)$2.2B
QuidelOrtho (QDEL)$1.8B
AtriCure (ATRC)$1.8B
Curaleaf Holdings (CURLF)$1.7B